{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:57:22Z","timestamp":1792547842314,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.047","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T09:50:44Z","timestamp":1419328244000},"page":"365-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Serum chemokine CCL17\/thymus activation and regulated chemokine is correlated with coronary artery diseases"],"prefix":"10.1016","volume":"238","author":[{"given":"Yicong","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00395-005-0511-6","article-title":"Inflammatory mediators in atherosclerotic vascular disease","volume":"100","author":"Zernecke","year":"2005","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/emmm.201100183","article-title":"Chemokines: established and novel targets in atherosclerosis","volume":"3","author":"Koenen","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/07853890310019961","article-title":"Chemokines and atherosclerosis","volume":"36","author":"Sheikine","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1155\/MI.2005.175","article-title":"Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction","volume":"2005","author":"Arakelyan","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09629350410001664752","article-title":"Monocyte chemoattractant protein-1 in patients with peripheral arterial disease","volume":"13","author":"Petrkova","year":"2004","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A\u00a0transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions","volume":"24","author":"Wuttge","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.atherosclerosis.2005.11.025","article-title":"Decreased plasma CXCL16\/SR-PSOX concentration is associated with coronary artery disease","volume":"188","author":"Sheikine","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib10","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijcard.2014.07.028","article-title":"Association between serum chemokine CC-motif ligand 17 and coronary artery disease","volume":"176","author":"Ye","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib12","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib13","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Task Force Members","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A\u00a0more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib16","first-page":"1462","article-title":"2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur. Heart J."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2014.12.047_bib17","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases","volume":"43","author":"Saeki","year":"2006","journal-title":"J.\u00a0Dermatol Sci."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jaad.2014.07.031","article-title":"Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity","volume":"71","author":"Landheer","year":"2014","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.12719","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) levels reflect the disease activity in a patient with bullous pemphigoid","author":"Nin-Asai","year":"2014","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.21.6.923","article-title":"Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions","volume":"21","author":"Greaves","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0049-3848(00)00402-3","article-title":"The CC chemokines MDC and TARC induce platelet activation via CCR4","volume":"101","author":"Abi-Younes","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2014.12.047_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood.V97.4.937","article-title":"Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function","volume":"97","author":"Gear","year":"2001","journal-title":"Blood"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:52:07Z","timestamp":1537991527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014016694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0021915014016694"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.047","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum chemokine CCL17\/thymus activation and regulated chemokine is correlated with coronary artery diseases","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}